Uncategorized

05
May

Ready for an FDA Inspection? Be prepared. Read our Contract Pharma article.

Being proactive is always better than being reactive. And when it comes to a possible “visit” from FDA, anticipation and preparation go a long way in lowering anxiety and navigating the process successfully. Knock, knock. When an FDA investigator walks into your facility informing that they are going to conduct an inspection, a tense moment […]

Read More
05
May

Lachman to Participate in ISPE Europe in Amsterdam May 8 – 10

We are pleased to announce that Lachman Consultants will participate at ISPE Europe, May 8 – 10, in Amsterdam, The Netherlands. As in years past, Lachman will exhibit at this year’s event. Attendees will include: Michele Sinoway, Associate Director, Client Engagement Martha Ni Chuanaigh, Director, Client Operations Scott Deckebach, Senior Director The conference brings together […]

Read More
17
Nov

Did you miss the Outsourced Facilities Management Learning Experience?

Outsourcing your facilities management program is a great way to reduce the burden on internal resources—but it can also expose your business to greater risk and non-compliance. We’ve got you covered. Earlier this month, Lachman Consultants’ Data Integrity Consultant Patrick Day hosted an insightful and interactive webinar, Outsourced Facilities Management, aimed at helping businesses manage […]

Read More
02
Nov

A LIVE ROUNDTABLE WITH THE EXPERTS: The Importance of Maintaining Data Integrity in Digital Transformation Strategies

Wednesday, November 16th, 10:00 AM ET Presented by Informa Pharma Intelligence and Lachman Consultants HOSTED BY Maire Gerrard Managing Editor, Custom Content, Pharma Intelligence The life sciences industry is currently experiencing a period of sweeping digital transformation, propelled by initiatives like Pharma 4.0™ and progress in embedding artificial intelligence (AI), machine learning (ML), and robotic […]

Read More
02
Nov

Bob Pollock Appointed to Dispensary of Hope National Advisory Council

Dispensary of Hope, a Nashville-based organization with a national model of medication access for the most vulnerable, has appointed Robert “Bob” Pollock, M.S., Senior Advisor, Outside Director to the Board at Lachman Consultants, Inc. to its National Advisory Council. The organization’s many years of growth and commitment to serve are empowered by individual servants and […]

Read More
07
Oct

Managing Risks of an Outsourced Facilities Management Program Webinar

Join Lachman Consultants’ Data Integrity Consultant Patrick Day for a live webinar, Outsourced Facilities Management. The 90-minute session will be held on November 9th at 10:00 am EST and November 16th at 1:30 pm EST. A manufacturing operation is only as good as the facility that supports it. As more businesses outsource their facilities management […]

Read More
04
Oct

Connect with Lachman Consultants at the 2022 ISPE Annual Meeting

ISPE 2022 Annual Meeting Gaylord Palms Resort & Convention Center Orlando, FL October 30th – November 2nd, 2022 We are looking forward to seeing you at the 2022 ISPE Annual Meeting & Expo. This annual event will usher in a revitalized focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing. FEATURED SPEAKER Day […]

Read More
04
Aug

Responding to Consumer Complaints While Working with CMOs

Ricki Chase, M.S., Vice President, Lachman Consultant Services, Inc. (Lachman Consultants) and Carrie Colella, Senior Director, Lachman Consultant Services, Inc. (Lachman Consultants) take an in-depth look at the questions and challenges manufacturers face and how to respond to consumer product complaints while working with a contract manufacturing organization (CMO). The product, in this case, may […]

Read More
06
Jul

Ripple Effects of Expediting Vaccine Development

Recently I had the opportunity to make a presentation to the CPHI Learning Lab on the topic of The Ripple Effect of Expediting Vaccine Development and the profound social, economic, and operational effects the COVID-19 pandemic has had on our industry. On February 4, 2020, the Department of Health and Human Services (“HHS”) issued the […]

Read More
27
Jun

CONTRACT PHARMA ARTICLE: ICH – Q14 Regulatory Report

CONTRACT PHARMA ARTICLE: ICH – Q14 Regulatory Report: Analytical Procedure Development Paul Mason, Ph.D., Senior Director at Lachman Consultant Services, Inc., offers analysis and commentary on the draft of the new ICH Quality Guideline, ICH Q14, Analytical Procedure Development, and revision of ICH Q2(R2), Guideline on Validation of Analytical Procedures. In this informative article, Paul […]

Read More
1 2 6